TIPIFARNIB: 25 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
25
Total FAERS Reports
5 (20.0%)
Deaths Reported
5
Hospitalizations
25
As Primary/Secondary Suspect
1
Life-Threatening
First Report: 20000724 · Latest Report: 20220605
What Are the Most Common TIPIFARNIB Side Effects?
#1 Most Reported
Treatment failure
8 reports (32.0%)
#2 Most Reported
Thrombocytopenia
5 reports (20.0%)
#3 Most Reported
Malignant neoplasm progression
4 reports (16.0%)
All TIPIFARNIB Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Treatment failure | 8 | 32.0% | 1 | 0 |
| Thrombocytopenia | 5 | 20.0% | 2 | 1 |
Who Reports TIPIFARNIB Side Effects? Age & Gender Data
Gender: 16.7% female, 83.3% male. Average age: 56.1 years. Most reports from: US. View detailed demographics →
Is TIPIFARNIB Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2000 | 1 | 0 | 1 |
| 2001 | 1 | 1 | 0 |
| 2005 | 1 | 1 | 1 |
| 2007 | 1 | 1 | 0 |
| 2008 | 2 | 0 | 0 |
| 2015 | 1 | 0 | 1 |
| 2017 | 1 | 0 | 0 |
| 2022 | 1 | 0 | 1 |
What Is TIPIFARNIB Used For?
| Indication | Reports |
|---|---|
| Chronic myeloid leukaemia | 8 |
| Breast cancer metastatic | 5 |
Official FDA Label for TIPIFARNIB
Official prescribing information from the FDA-approved drug label.